HIGHLIGHTS
- who: Facts and collaborators from the Center of Integrative Genomics, Faculty of Biology and Medicine, University of Lausanne, Lausanne, Switzerland have published the paper: Peroxisome Proliferator-Activated Receptor u03b2/u03b4 in the Brain: Facts and Hypothesis, in the Journal: (JOURNAL)
- what: In this last section, the authors will therefore review studies that have explored PPARu03b2 targeted therapeutics for a variety of brain diseases.
- how: This review proposes different leads for future researches.
- future: High concentrations of GW742 (50 u03bcM) are required to observe this effect and further in_vivo studies are required . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.